Clinical Trials Logo

Clinical Trial Summary

The primary objective is to investigate the effects of lofexidine in adults undergoing opioid tapering prior to elective lumbar spine surgery.


Clinical Trial Description

In this clinical trial, an open label design will be used to facilitate opioid tapering during a 12-day period prior to elective spine surgery. The primary outcome measure of this study is the number of patients who achieve a 50% reduction in daily opioid dose at day 12. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04126083
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase Phase 4
Start date September 1, 2019
Completion date April 15, 2021

See also
  Status Clinical Trial Phase
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Completed NCT04140955 - Opioid Tapering After Spine Surgery N/A
Not yet recruiting NCT03813095 - Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction Phase 2
Completed NCT01262092 - Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals Phase 2
Completed NCT04075214 - Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal N/A
Recruiting NCT04325659 - An Innovative Intervention for OUD Treatment Phase 2/Phase 3
Terminated NCT04162145 - BRIDGE Device for Treatment of Opioid Withdrawal N/A
Withdrawn NCT03678792 - Comparison of Three Opioid Detoxification Treatment Regimens Phase 3
Completed NCT04238754 - Oral Cannabidiol for Opioid Withdrawal Phase 1/Phase 2
Recruiting NCT05053503 - Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder N/A
Recruiting NCT05555485 - Understanding the Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain N/A
Recruiting NCT03485430 - Tapering From Long-term Opioid Therapy in Chronic Pain Population. Randomized Controlled Trial With 12 Months Follow up N/A
Recruiting NCT05790551 - Suboxone Dispenser for OUD N/A
Completed NCT03174067 - Buprenorphine in the Emergency Department Phase 4
Completed NCT04731935 - Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal N/A
Completed NCT04470050 - Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal Phase 1/Phase 2
Recruiting NCT05307458 - Evaluating the Pharmacokinetics and Patient Outcomes of Buprenorphine Microdosing
Completed NCT03789214 - Medical Management of Sleep Disturbance During Opioid Tapering Phase 2
Recruiting NCT04759703 - Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD Phase 2/Phase 3
Completed NCT03017430 - Pregabalin for Opiate Withdrawal Syndrome Phase 4